The US could be the beneficiary of a potential blanket ban on the use of PFAS, better known as ‘forever chemicals’.
Samsung Biologics has secured a record $1.41 billion contract with an unnamed European pharmaceutical company, the contract ...
The EU’s increasing reliance on pharmaceutical production from non-EU countries, particularly India and China, has raised serious concerns, newly elected Czech MEP OndÅ™ej Dostál (NI ...
Health Care Without Harm aims to transform global healthcare to minimize its environmental impact and promote sustainability ...
Poland’s pharmaceutical industry says there’s still a long journey ahead for the revision of the EU’s pharma legislation. Despite the Pharma Package now heading to Council, the Polish ...